NCT04112927 Acoustic OSA Prediction During Wakefulness and Monitoring During Sleep
| NCT ID | NCT04112927 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Obstructive Sleep Apnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2021-10-01 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2021-10-01 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the feasibility of sound analysis for: a) sleep apnea detection both during wakefulness and sleep, and b) flow-sound relationship during both wakefulness and sleep in patients and control individuals. The ultimate goal of our research is to simplify the current assessments for sleep apnea detection so that it is more convenient for patients and also much faster than the current techniques.
Eligibility Criteria
Inclusion Criteria: * 1\) age between 18 to 70 years. * 2\) suspected of OSA and referred to full PSG study by a doctor. Exclusion Criteria: * 1\) being diagnosed with a chronic respiratory disease including pulmonary fibrosis, emphysema, respiratory infectious disease, nocturnal asthma, obstructive pulmonary lung disease, pulmonary hypertension, congestive heart failure, sleep related hypoventilation and neuromuscular disorders. * 2\) having insomnia or restless leg. * 3\) drug addiction. * 4\) under the current, direct supervision of the PI of this study.
Contact & Investigator
Zahra Kazem-Moussavi, Ph.D.
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT04112927 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04112927 currently recruiting?
Yes, NCT04112927 is actively recruiting participants. Contact the research team at abnoorkaur9@gmail.com for enrollment information.
Where is the NCT04112927 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT04112927 clinical trial?
NCT04112927 is sponsored by University of Manitoba. The principal investigator is Zahra Kazem-Moussavi, Ph.D. at University of Manitoba. The trial plans to enroll 250 participants.